Skip to main content
. 2018 Mar 7;11(2):546–551. doi: 10.1016/j.tranon.2018.02.008

Table 2.

Tumor and Proliferation Markers in High-Grade Serous Carcinoma (HGSC) vs. Other Epithelial Ovarian Tumorsa

HGSC
Other Tumorsa
P
(n = 26)
(n = 43)
n % n %
Tumor marker
 p53b 24 92.3 10c 23.8 <.001
 p16d 26 100 26 60.5 <.001
Proliferation marker
 Ki67e 19 73.1 16 37.2 <.005
a

Other tumors = endometrioid carcinoma, clear cell carcinoma, mucinous carcinoma, low-grade serous carcinoma, carcinosarcoma, mixed tumor, non-differentiated carcinoma, mucinous cystadenoma and borderline ovarian tumor.

b

Tumors were scored with respect to distribution (0-4) and intensity (1-3) of immunoreactivity. An immunohistochemical composite score was calculated by multiplying the distribution and intensity scores (0-12). Score 0 and 12 were considered as p53 mutation.

c

One case was not evaluated due to technical problems with immunohistochemical staining.

d

>25% Moderat/intense diffuse nuclear staining was considered as p16 mutation.

e

High Ki67 proliferation (> 25% stained cells).